- Home
- RPRX vs CHRW Comparison
RPRX vs CHRW Comparison
Compare RPRX & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | CHRW |
|---|---|---|
| Founded | 1996 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 23.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RPRX | CHRW |
|---|---|---|
| Price | $46.15 | $170.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 20 |
| Target Price | $47.75 | ★ $174.53 |
| AVG Volume (30 Days) | ★ 2.7M | 1.8M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.06% | 1.49% |
| EPS Growth | N/A | ★ 25.13 |
| EPS | 1.78 | ★ 4.83 |
| Revenue | $2,378,193,000.00 | ★ $14,869,380,000.00 |
| Revenue This Year | $38.30 | $4.37 |
| Revenue Next Year | $4.80 | $6.50 |
| P/E Ratio | ★ $25.63 | $35.05 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $84.68 |
| 52 Week High | $47.86 | $203.34 |
Technical Indicators
Market Signals| Indicator | RPRX | CHRW |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 40.01 |
| Support Level | $44.94 | $148.27 |
| Resistance Level | $46.14 | $194.54 |
| Average True Range (ATR) | 0.92 | 6.53 |
| MACD | -0.23 | -1.95 |
| Stochastic Oscillator | 39.36 | 9.56 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.